PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search > PAD Profile : HRT continuous combined - Menopausal disorders

PAD Profile : HRT continuous combined - Menopausal disorders

Keywords :
Oestrogen, medroxyprogesterone, Estradiol, Norethisterone, dydrogesterone, Menopause, hot sweats, mood swings, anxiety, weight gain, post menopausal, patch, oral tablet, transdermal, hormone replacement therapy, conjugated oestrogens
Brand Names Include :
Femoston Conti, Indivina, Elleste Duet Conti, Kliofem, Premique low dose, Evorel Conti, FemSeven Conti, Kliovance

Traffic Light Status

Status 1 of 1.

Status :
See Below
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
01 May 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the Patient Information Leaflet (PIL) to support patients taking off label continuous combined HRT

04 March 2020
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey & North West Sussex Area Prescribing Committee updated their recommendations in line with NICE guidance NG23 Menopause diagnosis and management in May 2020.

Please see the attached document below (Continuous combined HRT  -  traffic light status - December 2020) for information on the traffic light status for these drugs.
For more information please refer to the briefing paper and the full NICE guidance.

Associated BNF Codes

06. Endocrine System
06.04.01. Female sex hormones and their modulators
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More